Charles W Newhall III
CIK 1005544 · View on SEC EDGAR ↗
First SEC filing: Oct. 11, 2012 · Latest: Feb. 8, 2023
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 27, 2025 | SUPN | S 10b5-1 | 3,588 | $45.01 | $161,496 | 129,644 Direct | -2.69% | Disposed | 5.4% (price as of 2026-08-21) |
| Aug. 25, 2025 | SUPN | S 10b5-1 | 1,000 | $45.00 | $45,000 | 133,232 Direct | -0.74% | Disposed | 5.4% (price as of 2026-08-21) |
| Aug. 22, 2025 | SUPN | S 10b5-1 | 1,412 | $45.00 | $63,540 | 134,232 Direct | -1.04% | Disposed | 5.4% (price as of 2026-08-21) |
| Nov. 16, 2023 | SUPN | S | 2,500 | $28.01 | $70,025 | 117,089 Direct | -2.09% | Disposed | 69.3% (price as of 2026-08-21) |
| May 4, 2012 | SUPN | P | 4,400,000 | $5.00 | $22,000,000 | 10,641,250 Indirect | +70.50% | Acquired | 848.4% (price as of 2026-08-21) |
| April 12, 2006 | GYRE | P | 350,000 | $9.00 | $3,150,000 | 350,000 Indirect | — | Acquired | -100.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | SUPN | Restricted Stock Unit | Common Stock (4,475) | — | — | 4,475 | Disposed |
| Feb. 18, 2026 | SUPN | Director Stock Option (Right to Buy) | Common Stock (4,977) | $50.20 | Feb. 18, 2036 | 4,977 | Acquired |
| Feb. 18, 2026 | SUPN | Restricted Stock Unit | Common Stock (2,989) | — | — | 2,989 | Acquired |
| Feb. 23, 2024 | SUPN | Restricted Stock Unit | Common Stock (3,886) | — | — | 3,886 | Disposed |
| Feb. 22, 2024 | SUPN | Restricted Stock Units | Common Stock (5,369) | — | — | 5,369 | Acquired |
| Feb. 22, 2024 | SUPN | Director Stock Option (Right to Buy) | Common Stock (8,252) | $27.94 | Feb. 22, 2034 | 8,252 | Acquired |
| Nov. 16, 2023 | SUPN | Director Stock Option (Right to Buy) | Common Stock (7,457) | $9.24 | Jan. 21, 2024 | 7,457 | Disposed |
| Feb. 23, 2023 | SUPN | Restricted Stock Units | Common Stock (3,886) | — | — | 3,886 | Acquired |
| Feb. 23, 2023 | SUPN | Director Stock Option (Right to Buy) | Common Stock (6,293) | $38.60 | Feb. 23, 2033 | 6,293 | Acquired |
| Feb. 22, 2023 | SUPN | Restricted Stock Units | Common Stock (3,882) | — | — | 3,882 | Disposed |
| Dec. 28, 2022 | SUPN | Director Stock Option (Right to Buy) | Common Stock (8,722) | $7.90 | Feb. 5, 2023 | 8,722 | Disposed |
| Feb. 22, 2022 | SUPN | Director Stock Option (Right to Buy) | Common Stock (6,847) | $32.20 | Feb. 22, 2032 | 6,847 | Acquired |
| Feb. 22, 2022 | SUPN | Restricted Stock Units | Common Stock (3,882) | — | — | 3,882 | Acquired |
| Feb. 19, 2022 | SUPN | Restricted Stock Units | Common Stock (4,222) | — | — | 4,222 | Disposed |
| Feb. 19, 2021 | SUPN | Restricted Stock Units | Common Stock (4,222) | — | — | 4,222 | Acquired |
| Feb. 19, 2021 | SUPN | Director Stock Option (Right to Buy) | Common Stock (7,365) | $29.61 | Feb. 19, 2031 | 7,365 | Acquired |
| Feb. 21, 2020 | SUPN | Director Stock Option (Right to Buy) | Common Stock (9,305) | $23.99 | Feb. 21, 2030 | 9,305 | Acquired |
| Feb. 22, 2019 | SUPN | Director Stock Option (Right to Buy) | Common Stock (12,427) | $36.75 | Feb. 22, 2029 | 12,427 | Acquired |
| Feb. 23, 2018 | SUPN | Director Stock Option (Right to Buy) | Common Stock (8,613) | $39.40 | Feb. 23, 2028 | 8,613 | Acquired |
| June 13, 2017 | SUPN | Director Stock Option (Right to Buy) | Common Stock (6,036) | $38.60 | June 13, 2027 | 6,036 | Acquired |
| Feb. 24, 2017 | SUPN | Director Stock Option (Right to Buy) | Common Stock (7,905) | $25.30 | Feb. 24, 2027 | 7,905 | Acquired |
| March 1, 2016 | SUPN | Director Stock Option (Right to Buy) | Common Stock (15,000) | $12.98 | March 1, 2026 | 15,000 | Acquired |
| March 3, 2015 | SUPN | Director Stock Option (Right to Buy) | Common Stock (20,000) | $9.13 | March 3, 2025 | 20,000 | Acquired |
| Jan. 21, 2014 | SUPN | Director Stock Option (Right to Buy) | Common Stock (7,457) | $9.24 | Jan. 21, 2024 | 7,457 | Acquired |
| Feb. 5, 2013 | SUPN | Director Stock Option (Right to Buy) | Common Stock (8,722) | $7.90 | Feb. 5, 2023 | 8,722 | Acquired |
| Oct. 17, 2012 | WDAY | Class B Common Stock | Class A Common Stock [F3] (6,963,636) | — | — | 6,963,636 | Acquired |
| Oct. 17, 2012 | WDAY | Series E Convertible Preferred Stock | Class B Common Stock [F2,F3] (6,963,636) | — | — | 6,963,636 | Disposed |
| May 4, 2012 | SUPN | Series A Preferred Stock | Common Stock (6,241,250) | — | — | 24,965,000 | Disposed |
| Feb. 6, 2007 | GYRE | Stock Option (Right to Buy) | Common Stock (1,000) | $0.08 | — | 1,000 | Disposed |
| April 18, 2006 | GYRE | Series C Preferred Stock | Common Stock (2,913,512) | — | — | 20,226,034 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 11, 2012 | WDAY | Series E Convertible Preferred Stock→ Class B Common Stock [F2,F3] (6,963,636) | 6,963,636 | Indirect |
| April 30, 2012 | SUPN | Series A Preferred Stock→ Common Stock (6,241,250) | 6,241,250 | Indirect |
| Nov. 3, 2011 | GRPN | Class A Common Stock | 87,184,956 | Indirect |
| April 11, 2006 | GYRE | Common Stock | 1,000 | Indirect |
| April 11, 2006 | GYRE | Series C Preferred Stock→ Common Stock (2,913,512) | 2,913,512 | Indirect |
| April 11, 2006 | GYRE | Stock Option (Right to Buy)→ Common Stock (3,333) | 3,333 | Indirect |
| April 11, 2006 | GYRE | Stock Option (Right to Buy)→ Common Stock (1,000) | 1,000 | Indirect |
| April 11, 2006 | GYRE | Stock Option (Right to Buy)→ Common Stock (1,000) | 1,000 | Indirect |